It’s in your genes. These are some of the largest companies by market cap engaged in innovative CRISPR or gene editing research.

CRISPR technology

CRISPR technology has dramatically lowered the time and cost of genome editing in medical research and according to [[link1]], “will likely change the world.” According to [[link2]], the worldwide market for CRISPR technology will grow by nearly 20% annually through 2027.

Governments are still developing regulations around CRISPR, which may affect demand. Also, the ethical debate and risks associated with CRISPR may result in [[link3]] that curb its growth.

Explore pre-built stock collections at Wealthfront. Discover stocks through investing themes and opportunities. Get started with $1 and invest with zero commissions.